Published in Healthcare Finance, Tax and Law Weekly, June 30th, 2004
The company believes the listing process is on the right track and while the company has no control over such a listing, it feels it meets the requirements of the American Stock Exchange and will cooperate fully to achieve listing by the end of 2004.
Shujun Liu, CEO of American Oriental Bioengineering, commented, "We are fully cooperating with AMEX and are taking all actions to speed up the listing process. A listing on AMEX is a logical step given our strong business fundamentals, profitability, and outlook...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.